Background: In a previous work, we demonstrated with flow cytometry (FCM) methods that accumulation of human cyclin B1 in leukemic cell lines begins during the G 1 phase of the cell cycle (Viallard et al., Exp Cell Res 247: 208-219, 1999). In the present study, FCM was used to compare the localizati
Media conditioned by human leukemic T-cells induce expression of IL2 receptors and proliferation of normal T lymphocytes
✍ Scribed by Constantinos Kosmatopoulos; Michèle Allouche; Frédéric Triebel; Maria Zanti; Corine Clemenceau; Jean-Claude Gluckman; Claude Jasmin; Vassilis Georgoulias
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- French
- Weight
- 768 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Percentage positive cells. -'Cells incubated in TPA (10 ng/ml) or in culture medium only at a cell concentration of 2 X lo5 celldwell and tested for marker expression at day 3. Cell recoveries were 40% and 24 % for TPA and medium incubation, respectively. -'ND, not determined.
Resting human T lymphocytes do not express receptors for interleukin-2, but expression is rapidly induced by exposure to PHA. After maximal expression 2-3 days after stimulation, a progressive decline in receptor number is observed. Receptor expression can be augmented by reexposure to PHA. In this
Genetic engineering of human T lymphocytes to express tumor antigen-specific chimeric immune receptors is an attractive means for providing large numbers of effector cells for adoptive immunotherapy while bypassing major mechanisms of tumor escape from immune recognition. We have applied this strate
## Abstract Peripheral blood T cells from a patient with T‐cell chronic lymphocytic leukemia (T‐CLL) failed to respond to mitogenic lectins or alloantigens but could be induced to proliferate by the addition of exogenous interleukin‐2 (IL‐2). The T‐CLL cells also proliferated in response to 12‐__O_